DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.


Player Avatar pchop123 (80.46) Submitted: 2/25/2013 3:39:27 PM : Underperform Start Price: $6.25 DEPO Score: +7.96

share price likely to continue to drop on less than steller EPS & expectations

Featured Broker Partners